BVL
BMY icon

Beau Ventures, LLc’s Bristol-Myers Squibb BMY Stock Holding History

Beau Ventures, LLc’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.27M Sell
100,515
-67
-0.1% -$4.23K 0.59% 13
2026
Q2 		$5.8M Buy
100,582
+377
+0.4% +$21.6K 0.63% 13
2026
Q1 		$6.08M Buy
100,205
+138
+0.1% +$8.04K 0.81% 12
2025
Q4 		$5.4M Buy
+100,067
New +$4.81M 0.67% 13

Other funds holding BMY

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
VFM
Viking Fund Management Minot, North Dakota $1.14B AUM 32.65% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return

Beau Ventures, LLc's BMY Position: Q3 2026 in Review

Beau Ventures, LLc reduced its Bristol-Myers Squibb (BMY) stake by 0.07% in Q3 2026, selling an estimated $4.23K and leaving 100,515 shares worth $6.27M. The position accounts for 0.59% of the portfolio, ranked #13.

Beau Ventures, LLc first reported a position in BMY in Q4 2025 and has held it in 4 quarters since. 276 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Beau Ventures, LLc held 100,515 shares of Bristol-Myers Squibb worth $6.27M as of Q3 2026.
  • Beau Ventures, LLc sold 67 Bristol-Myers Squibb shares in Q3 2026, an estimated $4.23K.
  • Bristol-Myers Squibb made up 0.59% of Beau Ventures, LLc's portfolio in Q3 2026, its #13 holding.
  • Beau Ventures, LLc first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 4 quarters since.
  • 276 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Beau Ventures, LLc's 13F filing for Q3 2026, filed 14 Oct 2026.